DANIEL VASELLA, MD - Corporate Board Profile

PEPSICO INC

Filing Date	Source Excerpt
2014-03-21	DANIEL VASELLA, MD, 60, was elected to our Board of Directors in 2002. Committee Memberships: Compensation Committee, Nominating and Corporate Governance Committee. 2013 Director Compensation: $216,025.
2015-03-25	Daniel Vasella, MD, served as Chairman of the Board of Novartis AG, a global innovative healthcare solutions company, from 1999 until 2013 and as Chief Executive Officer of Novartis AG from 1996 to January 2010.
2016-03-18	Daniel Vasella, MD, served as Chairman of the Board of Novartis AG, a global innovative healthcare solutions company, from 1999 until 2013 and as Chief Executive Officer of Novartis AG from 1996 to January 2010. From 1992 to 1996, Dr. Vasella held the positions of Chief Executive Officer, Chief Operating Officer, Senior Vice President and Head of Worldwide Development and Head of Corporate Marketing at Sandoz Pharma Ltd. He also served at Sandoz Pharmaceuticals Corporation from 1988 to 1992. Dr. Vasella is also a director of American Express Company and XBiotech Inc.
2017-03-17	Daniel Vasella, MD, served as Chairman and CEO of Novartis AG... Independent Committee Memberships: Compensation, Nominating and Corporate Governance (Chair)... 2016 Non-Employee Director Compensation: Daniel Vasella - Total: $315,000.
2019-03-22	Daniel Vasella, MD, served as Chairman of Novartis AG, a global innovative healthcare solutions company, from 1999 to 2013 and as Chief Executive Officer of Novartis AG from 1996 to January 2010. From 1992 to 1996, Dr. Vasella held the positions of Chief Executive Officer, Chief Operating Officer, Senior Vice President and Head of Worldwide Development and Head of Corporate Marketing at Sandoz Pharma Ltd. He also served at Sandoz Pharmaceuticals Corporation from 1988 to 1992. Dr. Vasella is currently working as a coach to senior executives. He is also a member of several non-profit organizations, including as a trustee of the Carnegie Endowment for International Peace. Other Public Company Directorships: Current: American Express Company. Committee Memberships: Compensation, Nominating and Corporate Governance (Chair). 2018 Director Compensation: $330,000.
2020-03-20	Daniel Vasella, MD, served as Chairman of Novartis AG, a global innovative healthcare solutions company, from 1999 to 2013 and as Chief Executive Officer of Novartis AG from 1996 to January 2010. From 1992 to 1996, Dr. Vasella held the positions of Chief Executive Officer, Chief Operating Officer, Senior Vice President and Head of Worldwide Development and Head of Corporate Marketing at Sandoz Pharma Ltd. He also served at Sandoz Pharmaceuticals Corporation from 1988 to 1992. Dr. Vasella is currently working as a coach to senior executives. He also serves on the board of Numab Therapeutics AG, an emerging biotechnology company, and as a member of several private and non-profit organizations.
2022-03-24	Daniel Vasella, MD, served as Chairman of Novartis AG, a global innovative healthcare solutions company, from 1999 to 2013 and as Chief Executive Officer of Novartis AG from 1996 to 2010. From 1992 to 1996, Dr. Vasella held the positions of Chief Executive Officer, Chief Operating Officer, Senior Vice President and Head of Worldwide Development and Head of Corporate Marketing at Sandoz Pharma Ltd. He also served at Sandoz Pharmaceuticals Corporation from 1988 to 1992. Dr. Vasella is currently working as a coach to senior executives. He also serves as chair of the board of Numab Therapeutics AG, a biotechnology company, and on the boards of several private companies and non-profit organizations. 2021 Non-Employee Director Compensation: Daniel Vasella Fees Earned or Paid in Cash ($) 132,500 Stock Awards ($) 190,000 All Other Compensation ($) 11,208 Total ($) 333,708
2023-03-21	Daniel Vasella, MD, served as Chairman and CEO of Novartis AG. Non-employee director compensation: Fees Earned or Paid in Cash $120,000; Stock Awards $200,000; All Other Compensation $10,222; Total $330,222.
2024-03-22	Daniel Vasella, MD, served as Chairman of Novartis AG, a global innovative healthcare solutions company, from 1999 to 2013 and as Chief Executive Officer of Novartis AG from 1996 to 2010. From 1992 to 1996, Dr. Vasella held the positions of Chief Executive Officer, Chief Operating Officer, Senior Vice President and Head of Worldwide Development and Head of Corporate Marketing at Sandoz Pharma Ltd. He also served at Sandoz Pharmaceuticals Corporation from 1988 to 1992. Dr. Vasella is currently working as a coach to senior executives. He also serves on the boards of several private companies. Other Public Company Directorships: Current: American Express Company; SciClone Pharmaceuticals (Holdings) Limited. Previous (During Past 5 Years): None. Dr. Vasella brings to our Board of Directors his expertise in the areas of nutrition and health and wellness, topics of importance to PepsiCo, as well as his leadership experience and global perspectives, which he obtained through his former role as Chairman and Chief Executive Officer of Novartis. Through his leadership of Novartis and his public company director experience, he also offers to PepsiCo extensive business, corporate governance, operations, management and marketing skills, as well as human capital management and talent development, succession planning and experience developing corporate strategy. In addition, he contributes his knowledge of and experience with regulatory matters developed through his role leading a highly regulated, global business in rapidly changing markets. 2023 Non-Employee Director Compensation: Daniel Vasella Fees Earned or Paid in Cash ($) 120,000 Stock Awards ($) 200,000 All Other Compensation ($) 20,000 Total ($) 340,000.
2025-03-28	Daniel Vasella, MD, served as Chairman of Novartis AG, a global innovative healthcare solutions company.